Pulmatrix Shares Outstanding 2014-2022 | PULM

Pulmatrix shares outstanding from 2014 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pulmatrix Annual Shares Outstanding
(Millions of Shares)
2021 3
2020 1
2019 1
2018 0
2017 0
2016 0
2015 0
2014 0
2014 0
2013
2013 0
2012 0
Pulmatrix Quarterly Shares Outstanding
(Millions of Shares)
2022-09-30 3
2022-06-30 3
2022-03-31 3
2021-12-31 3
2021-09-30 3
2021-06-30 3
2021-03-31 2
2020-12-31 1
2020-09-30 2
2020-06-30 1
2020-03-31 1
2019-12-31 1
2019-09-30 1
2019-06-30 1
2019-03-31 0
2018-12-31 0
2018-09-30 0
2018-06-30 0
2018-03-31 0
2017-12-31 0
2017-09-30 0
2017-06-30 0
2017-03-31 0
2016-12-31 0
2016-09-30 0
2016-06-30 0
2016-03-31 0
2015-12-31 0
2015-09-30 0
2015-06-30 0
2015-03-31 0
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31 0
2013-09-30 0
2013-06-30 0
2013-03-31 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.015B $0.005B
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $153.147B 9.34
GSK (GSK) United Kingdom $71.894B 8.95
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.086B 18.92
Ginkgo Bioworks Holdings (DNA) United States $3.531B 0.00
Myovant Sciences (MYOV) United Kingdom $2.613B 0.00
Arcus Biosciences (RCUS) United States $1.618B 24.29
Biohaven (BHVN) United States $1.266B 0.00
Emergent Biosolutions (EBS) United States $0.645B 5.07
ADC Therapeutics SA (ADCT) Switzerland $0.378B 0.00
Ambrx Biopharma (AMAM) United States $0.078B 0.00
Enzo Biochem (ENZ) United States $0.067B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.022B 0.00